Please Wait
Applying Filters...
menu
    • menu
    Excipient Market Overview: Evonik launches high-purity excipients; India mandates disclosures from March 2026

    Data Compilation
    #PharmaFlow

    Pipeline Prospector November 2025: Kimberly-Clark to buy Kenvue for US$ 48.7 bn; FDA approves Novartis’ gene therapy

    Stock Recap
    #PipelineProspector

    Menu

    Alfuzosin Hydrochloride

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 916Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Log in to download the data

    Last Updated on PharmaCompass Virtual Booth Country Registrant Name Registration No. Compound Registration Date Manufacturer Manufacturer's Country Manufacturer's Address
    29/11/2025 FARMAK, a.s
    Czech Republic
    		 Ankook Pharmaceutical Co., Ltd. 20200115-209-J-260(1) alfuzosin hydrochloride 2020-07-02 Farmak, as Czech Republic Na vlcinci 16/3, Klasterni Hradisko, 779 00 Olomouc, Czech Republic
    29/11/2025 FARMAK, a.s
    Czech Republic
    		 Iksoo Pharmaceutical Co., Ltd. 20200115-209-J-260 alfuzosin hydrochloride 2020-01-15 Farmak, as Czech Republic Na vlcinci 16/3, Klasterni Hradisko, 779 00 Olomouc, Czech Republic